Open-label, randomized, phase 3 trial to evaluate the efficacy and safety of Aztreonam for inhalation solution vs Tobramycin inhalation solution in an
Core Function(s):
Performing Research or Evaluation
Area of Emphasis
Health-Related Activities
Target Audience:
Professionals and Para-Professionals
Unserved or Under-served Populations:
Racial or Ethnic Minorities, Disadvantaged Circumstances, Limited English, Geographic Areas
Primary Target Audience Geographic Descriptor:
Regional
COVID-19 Related Data:
N/A